EMCDDA Home
  • EN
Search

EMCDDA–Europol 2009 Annual Report on the implementation of Council Decision 2005/387/JHA

EMCDDA, Lisbon, May 2010

Publication type:

Implementation reports

Summary:

This report presents the results and outlines the key achievements and challenges faced by mechanism set up by the Council Decision in 2009.

In 2009, 24 new psychoactive substances were officially notified for the first time in the European Union through the Early-Warning System (EWS). All new compounds were synthetic, including two substances with medicinal properties. Nine of the reported substances were synthetic cannabinoids from four distinct chemical groups. Beyond these, there was a mix of substances belonging to more established chemical families – five phenethylamines, two tryptamines and four synthetic cathinones. No new piperazines or psychoactive plants were reported.

The report also highlights the emergence of new, smokable herbal products laced with synthetic cannabinoids and the growing popularity of various synthetic cathinones as significant new developments in the field of so-called ‘legal highs’. Furthermore, the report includes a brief follow-up on the piperazine derivative mCPP, a brief threat assessment, a review of the EWS achievements, and a look into some of its challenges.

Download as pdf (312Kb):

English (en)

Table of contents

  • Introduction and background
  • Implementation arrangements and cooperation with the EU pharmacovigilance system
  • Results achieved in 2009
  • Outlook on future challenges
  • Conclusion

Pages:

25

Price:

free

ISBN/ISSN:

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. Read more >>

Contact us

EMCDDA
Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 11 May 2011